tiprankstipranks
Kiniksa Pharmaceuticals (KNSA)
NASDAQ:KNSA
US Market
KNSA
Kiniksa Pharmaceuticals
RESEARCH TOOLSreports
Want to see KNSA full AI Analyst Report?

Kiniksa Pharmaceuticals (KNSA) Income Statement

562 Followers

Kiniksa Pharmaceuticals Income Statement

Last quarter (Q1 2026), Kiniksa Pharmaceuticals's total revenue was $214.27M, an increase of 55.51% from the same quarter last year. In Q1, Kiniksa Pharmaceuticals's net income was $22.59M. See Kiniksa Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 677.56M$ 423.24M$ 270.26M$ 220.18M$ 38.54M
Gross Profit
$ 370.15M$ 362.33M$ 213.74M$ 197.28M$ 29.44M
Operating Expenses
$ 292.93M$ 407.94M$ 238.93M$ 187.51M$ 186.08M
Depreciation and Amortization
$ 1.55M$ 1.70M$ 2.34M$ 2.40M$ 2.35M
EBITDA
$ 90.42M$ -43.92M$ -22.86M$ 12.18M$ -154.28M
Operating Income
$ 77.22M$ -45.62M$ -25.20M$ 9.77M$ -156.64M
Other Income/Expenses
$ 11.65M$ 9.46M$ 8.54M$ 1.25M$ 97.00K
Pretax Income
$ 88.87M$ -36.15M$ -16.65M$ 11.03M$ -156.54M
Net Income
$ 59.01M$ -43.19M$ 14.08M$ 183.36M$ -157.92M
Per Share Metrics
Basic EPS
$ 0.80$ -0.60$ 0.20$ 2.64$ -2.30
Diluted EPS
$ 0.75$ -0.60$ 0.20$ 2.60$ -2.30
Weighted Average Shares Outstanding
 74.20M 71.42M 70.06M 69.38M 68.58M
Weighted Average Shares Outstanding (Diluted)
 78.98M 71.42M 71.92M 70.42M 68.58M
Currency in USD

Kiniksa Pharmaceuticals Earnings and Revenue History